Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

BOM/539551 stock hub

BOM/539551 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/539551is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

369.7B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/539551

In the news

Latest news · BOM/539551

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.6

P25 n/aP50 n/aP75 n/a

Trailing P/E47.5

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC20

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/539551 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

INR

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	11,411
Employees Change	-248%
Employees Change Percent	-2.13
Enterprise value	INR 374.9B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	General Medical and Surgical Hospitals
Last refreshed	2026-05-10
Market cap	INR 369.7B
Price	INR 1,820
Price currency	INR
Rev Per Employee	5,939,590.75x
Sic	8062
Symbol	bom/539551
Website	https://www.narayanahealth.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.11%
EV Earnings	48.13x
EV/EBIT	34.43x
EV/EBITDA	27.05x
EV/Sales	5.53x
Forward P/E	33.58x
P/B ratio	9.1x
P/E ratio	47.46x
P/S ratio	5.45x
PE Ratio10 Y	69.43x
PE Ratio3 Y	36.4x
PE Ratio5 Y	37.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.12%
EBITDA Margin	19.84%
Gross margin	41.75%
Gross Profit	INR 28.3B
Gross Profit Growth	39.99%
Gross Profit Growth Q	65.1%
Gross Profit Growth3 Y	22.45%
Gross Profit Growth5 Y	35.5%
Net Income	INR 7.8B
Net Income Growth	-0.6%
Net Income Growth Q	-34.33%
Net Income Growth3 Y	15.77%
Pretax Margin	13.72%
Profit Margin	11.49%
Profit Per Employee	INR 682,615
Roa5y	8.98
Roe5y	22.81
ROIC	19.98
Roic5y	19.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.42%
Cagr1y	-0.1%
Cagr3y	34.05%
Cagr5y	34.87%
Div CAGR3	21.64%
Div CAGR5	35.1%
EPS Growth	-0.62
EPS Growth Q	-34.32
EPS Growth3 Y	15.75
Revenue Growth	25.89x
Revenue Growth Q	57.4x
Revenue Growth3 Y	16.89x
Revenue Growth5 Y	22.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 18.2B
Debt	INR 23.4B
Debt EBITDA	INR 1.68
Debt Equity	INR 0.58
Equity	INR 40.6B
Interest Coverage	5.66
Net Cash	INR -5.2B
Net Cash By Market Cap	INR -1.4
Net Debt EBITDA	INR 0.38
Net Debt Equity	INR 0.13
Tangible Book Value	INR 38.2B
Tangible Book Value Per Share	INR 188

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	12.5%
Dividend Growth Years	3%
Dividend per share	INR 4.5
Dividend Years	4
Dividend Yield	0.25%
Ex Div Date	2025-08-01
Last Dividend	INR 4.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	541.2%
1Y total return	-0.1%
200-day SMA	1,814.1
3Y total return	140.93%
50-day SMA	1,748
50-day SMA vs 200-day SMA	50under200
5Y total return	346.13%
All Time High	2,371.6
All Time High Change	-23.27%
All Time High Date	2025-06-27
All Time Low	181.4
All Time Low Change	903.45%
All Time Low Date	2019-05-17
ATR	51.49
Ch YTD	-3.77
High	1,884.1
High52	2,371.6
High52 Date	2025-06-27
High52ch	-23.27%
Low	1,814
Low52	1,564.3
Low52 Date	2026-03-30
Low52ch	16.33%
Ma50ch	4.1%
Price vs 200-day SMA	0.31%
RSI	56.25
RSI Monthly	58.81
RSI Weekly	52.28
Sharpe ratio	0.15x
Sortino ratio	0.45
Total Return	0.24%
Tr YTD	-3.77
Tr1m	7.11%
Tr1w	1.54%
Tr3m	6.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 10.9B
Operating Income Growth	14.01
Operating Income Growth Q	3.35
Operating Income Growth3 Y	17.36
Operating margin	16.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65,951,307%
Shares Insiders	65.7%
Shares Institutions	14.32%
Shares Qo Q	-0.04%
Shares Yo Y	0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	14,639.25x
Bv Per Share	199.9
Ch10y	530.3
Ch1m	7.11
Ch1w	1.54
Ch1y	-0.34
Ch3m	6.11
Ch3y	139
Ch5y	342
Ch6m	0.51
Change	-2.27%
Change From Open	-0.76
Close	1,862.1
Days Gap	-1.53
Depreciation Amortization	2,524,677,500
Dollar Volume	55,067,454.8
Earnings Date	2026-05-26
EBIT	INR 10.9B
EBITDA	INR 13.4B
EPS	INR 38.34
F Score	2
Fiscal Year End	March
Founded	2,000
Graham Number	415.30252
Graham Upside	-77.18
Income Tax	INR 1.5B
Is Primary Listing	0
Last Earnings Date	2026-02-02
Last Report Date	2025-12-31
Lynch Fair Value	INR 605
Lynch Upside	-66.78
Ma150	1,808.1
Ma150ch	0.65%
Ma20	1,789.8
Ma20ch	1.67%
Next Earnings Date	2026-05-26
Open	1,833.7
Payment Date	2025-09-28
Position In Range	8.2
Price Date	2026-05-08
Price EBITDA	INR 27.49
Ptbv Ratio	9.68
Relative Volume	2.07x
Revenue	67,776,670,000x
Tax By Revenue	2.23x
Tax Rate	16.24%
Tr6m	0.51%
Volume	30,261

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BOM/539551 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$4.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+35.1%

3 consecutive years of growth

Total shareholder yield

+0.2%

Next ex-dividend date: 2025-08-01

Performance

BOM/539551 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/539551?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.3%

Share of float held by funds and institutions

Insider ownership

+65.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

BOM/539551 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.3

Neutral momentum band

Price vs 200-day MA

+0.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/539551

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/539551 stock rating?

bom/539551 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/539551 analysis?

The full report lives at /stocks/bom/539551/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/539551?

The latest report frames bom/539551 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/539551 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.